Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobukazu Fujimoto

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Respiratory Medicine Case Reports|November 21, 2022
Boerhaave syndrome presenting black pleural effusion: A case reportTakaaki Tanaka, Ryosuke Ikeuchi, Kazuya Hisamatsu, et al.
Carcinogenesis|April 26, 2012
Integrated analysis of genetic and epigenetic alterations reveals CpG island methylator phenotype associated with distinct clinical characters of lung adenocarcinomaKeiko Shinjo, Yasuyuki Okamoto, Byonggu An, et al.
Oncology Letters|January 2, 2016
DNA copy number gains in malignant pleural mesotheliomaMasashi Furukawa, Shinichi Toyooka, Tatsuro Hayashi, et al.
Molecular Cancer Therapeutics|April 17, 2008
A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-rasYanan Yang, Marie Wislez, Nobukazu Fujimoto, et al.
Translational Lung Cancer Research|July 18, 2020
Open-label, multicenter, randomized phase II study on docetaxel plus bevacizumab or pemetrexed plus bevacizumab for treatment of elderly (aged ≥75 years) patients with previously untreated advanced non-squamous non-small cell lung cancer: TORG1323Toshiyuki Kozuki, Naoyuki Nogami, Osamu Hataji, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Triple combination chemotherapy with cisplatin, docetaxel, and irinotecan for advanced non-small cell lung cancer: a phase I/II trialKatsuyuki Kiura, Nagio Takigawa, Yoshihiko Segawa, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2013
The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesotheliomaTakayuki Muraoka, Junichi Soh, Shinichi Toyooka, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
A phase I trial of afatinib and bevacizumab in chemo-naïve patients with advanced non-small-cell lung cancer harboring EGFR mutations: Okayama Lung Cancer Study Group Trial 1404Takashi Ninomiya, Naoyuki Nogami, Toshiyuki Kozuki, et al.
Journal of Cancer Research and Clinical Oncology|April 7, 2022
First and repeat rebiopsy for detecting EGFR T790M mutation in non-small-cell lung cancer: CS-Lung-003 prospective observational registry studyKenichiro Kudo, Kazuya Nishii, Go Makimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2019
Clinical Efficacy and Safety of Nivolumab: Results of a <u>M</u>ulticenter, Op<u>e</u>n-label, Single-a<u>r</u>m, Japanese Phase II study in Mal<u>i</u>gnant Pleural Meso<u>t</u>helioma (MERIT)Morihito Okada, Takashi Kijima, Keisuke Aoe, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Respiratory Medicine Case Reports|November 21, 2022
Boerhaave syndrome presenting black pleural effusion: A case reportTakaaki Tanaka, Ryosuke Ikeuchi, Kazuya Hisamatsu, et al.
Carcinogenesis|April 26, 2012
Integrated analysis of genetic and epigenetic alterations reveals CpG island methylator phenotype associated with distinct clinical characters of lung adenocarcinomaKeiko Shinjo, Yasuyuki Okamoto, Byonggu An, et al.
Oncology Letters|January 2, 2016
DNA copy number gains in malignant pleural mesotheliomaMasashi Furukawa, Shinichi Toyooka, Tatsuro Hayashi, et al.
Molecular Cancer Therapeutics|April 17, 2008
A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-rasYanan Yang, Marie Wislez, Nobukazu Fujimoto, et al.
Translational Lung Cancer Research|July 18, 2020
Open-label, multicenter, randomized phase II study on docetaxel plus bevacizumab or pemetrexed plus bevacizumab for treatment of elderly (aged ≥75 years) patients with previously untreated advanced non-squamous non-small cell lung cancer: TORG1323Toshiyuki Kozuki, Naoyuki Nogami, Osamu Hataji, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Triple combination chemotherapy with cisplatin, docetaxel, and irinotecan for advanced non-small cell lung cancer: a phase I/II trialKatsuyuki Kiura, Nagio Takigawa, Yoshihiko Segawa, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2013
The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesotheliomaTakayuki Muraoka, Junichi Soh, Shinichi Toyooka, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
A phase I trial of afatinib and bevacizumab in chemo-naïve patients with advanced non-small-cell lung cancer harboring EGFR mutations: Okayama Lung Cancer Study Group Trial 1404Takashi Ninomiya, Naoyuki Nogami, Toshiyuki Kozuki, et al.
Journal of Cancer Research and Clinical Oncology|April 7, 2022
First and repeat rebiopsy for detecting EGFR T790M mutation in non-small-cell lung cancer: CS-Lung-003 prospective observational registry studyKenichiro Kudo, Kazuya Nishii, Go Makimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2019
Clinical Efficacy and Safety of Nivolumab: Results of a <u>M</u>ulticenter, Op<u>e</u>n-label, Single-a<u>r</u>m, Japanese Phase II study in Mal<u>i</u>gnant Pleural Meso<u>t</u>helioma (MERIT)Morihito Okada, Takashi Kijima, Keisuke Aoe, et al.
Pageof 11